Kaveh Ardalan1, Christina K Zigler2, Kathryn S Torok2. 1. Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 2. Christina K. Zigler, MSEd, Kathryn S. Torok, MD: Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Abstract
OBJECTIVE: Localized scleroderma can negatively affect children's quality of life (QoL), but predictors of impact have not been well described. We sought to identify predictors of QoL impact in juvenile localized scleroderma patients. METHODS: We analyzed longitudinal data from a single-center cohort of juvenile localized scleroderma patients, using hierarchical generalized linear modeling (HGLM) to identify predictors of QoL impact. HGLM is useful for nested data and allows for evaluation of both time-variant and time-invariant predictors. RESULTS: The number of extracutaneous manifestations (ECMs; e.g., joint contracture and hemifacial atrophy) and female sex predicted negative QoL impact, defined as a Children's Dermatology Life Quality Index score >1 (P = 0.019 for ECMs and P = 0.002 for female sex). As the time since the initial visit increased, the odds of reporting a negative QoL impact decreased (P < 0.001). CONCLUSION: Our results suggest that ECMs, sex, and time since initial visit are more predictive of QoL impact in localized scleroderma than cutaneous features. Further study is required to determine which ECMs have the most impact on QoL, which factors underlie sex differences in QoL in localized scleroderma, and why increasing the time since the initial visit appears to be protective. An improved understanding of predictors of QoL impact may allow for the identification of patients at risk of poorer outcomes and for the tailoring of treatment and psychosocial support.
OBJECTIVE:Localized scleroderma can negatively affect children's quality of life (QoL), but predictors of impact have not been well described. We sought to identify predictors of QoL impact in juvenile localized sclerodermapatients. METHODS: We analyzed longitudinal data from a single-center cohort of juvenile localized sclerodermapatients, using hierarchical generalized linear modeling (HGLM) to identify predictors of QoL impact. HGLM is useful for nested data and allows for evaluation of both time-variant and time-invariant predictors. RESULTS: The number of extracutaneous manifestations (ECMs; e.g., joint contracture and hemifacial atrophy) and female sex predicted negative QoL impact, defined as a Children's Dermatology Life Quality Index score >1 (P = 0.019 for ECMs and P = 0.002 for female sex). As the time since the initial visit increased, the odds of reporting a negative QoL impact decreased (P < 0.001). CONCLUSION: Our results suggest that ECMs, sex, and time since initial visit are more predictive of QoL impact in localized scleroderma than cutaneous features. Further study is required to determine which ECMs have the most impact on QoL, which factors underlie sex differences in QoL in localized scleroderma, and why increasing the time since the initial visit appears to be protective. An improved understanding of predictors of QoL impact may allow for the identification of patients at risk of poorer outcomes and for the tailoring of treatment and psychosocial support.
Authors: Eileen M Baildam; Holly Ennis; Helen E Foster; Lindsay Shaw; Alice S E Chieng; Jane Kelly; Ariane L Herrick; Helen L Richards Journal: J Rheumatol Date: 2010-11-01 Impact factor: 4.666
Authors: Suzanne C Li; Kathryn S Torok; Elena Pope; Fatma Dedeoglu; Sandy Hong; Heidi T Jacobe; C Egla Rabinovich; Ronald M Laxer; Gloria C Higgins; Polly J Ferguson; Andrew Lasky; Kevin Baszis; Mara Becker; Sarah Campillo; Victoria Cartwright; Michael Cidon; Christi J Inman; Rita Jerath; Kathleen M O'Neil; Sheetal Vora; Andrew Zeft; Carol A Wallace; Norman T Ilowite; Robert C Fuhlbrigge Journal: Arthritis Care Res (Hoboken) Date: 2012-08 Impact factor: 4.794
Authors: Maja Bulatović; Marloes W Heijstek; Marleen Verkaaik; E H Pieter van Dijkhuizen; Wineke Armbrust; Esther P A Hoppenreijs; Sylvia Kamphuis; Wietse Kuis; Toine C G Egberts; Gerben Sinnema; Carin M A Rademaker; Nico M Wulffraat Journal: Arthritis Rheum Date: 2011-07
Authors: Thaschawee Arkachaisri; Soamarat Vilaiyuk; Suzanne Li; Kathleen M O'Neil; Elena Pope; Gloria C Higgins; Marilynn Punaro; Egla C Rabinovich; Margalit Rosenkranz; Daniel A Kietz; Paul Rosen; Steven J Spalding; Teresa R Hennon; Kathryn S Torok; Elaine Cassidy; Thomas A Medsger Journal: J Rheumatol Date: 2009-10-15 Impact factor: 4.666
Authors: M S Salek; S Jung; L A Brincat-Ruffini; L MacFarlane; M S Lewis-Jones; M K A Basra; A Y Finlay Journal: Br J Dermatol Date: 2013-10 Impact factor: 9.302
Authors: A Finzi; D Colombo; A Caputo; L Andreassi; S Chimenti; G Vena; L Simoni; S Sgarbi; A Giannetti Journal: J Eur Acad Dermatol Venereol Date: 2007-10 Impact factor: 6.166
Authors: Alina Skrzypek-Salamon; Anna Lis-Święty; Irmina Ranosz-Janicka; Ligia Brzezińska-Wcisło Journal: Health Qual Life Outcomes Date: 2018-09-14 Impact factor: 3.186
Authors: Kathryn S Torok; Suzanne C Li; Heidi M Jacobe; Sarah F Taber; Anne M Stevens; Francesco Zulian; Theresa T Lu Journal: Front Immunol Date: 2019-04-30 Impact factor: 7.561
Authors: Eveline Y Wu; Suzanne C Li; Kathryn S Torok; Yamini V Virkud; Robert C Fuhlbrigge; C Egla Rabinovich Journal: ACR Open Rheumatol Date: 2019-04-10